NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells-Reference-Cited by-同舟云学术

NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells

Published:2015-05-01 Issue:5 Volume:10 Page:e0123808
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jaiswal Aruna S.,Panda Harekrushna,Law Brian K.,Sharma Jay,Jani Jitesh,Hromas Robert,Narayan Satya

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Targeted cancer therapies: the future of cancer treatment;M Kumar;Acta Biomed

2. Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy;A Savonarola;Pharmacogenomics J,2012

3. Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: a review of mechanisms and outcomes;D McWhirter;Crit Rev Oncol Hematol,2013

4. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer;JJ Marin;Drug Metab Rev,2012

5. DNA repair in resistance to alkylating anticancer drugs;B Kaina;Int J Clin Pharmacol Ther,2002

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemicals as Potential DNA Polymerase β Inhibitors for Targeted Ovarian Cancer Therapy: An In-silico Approach;Biosciences Biotechnology Research Asia;2024-07-01

2. Impact and potential value of immunosenescence on solid gastrointestinal tumors;Frontiers in Immunology;2024-06-28

3. Impact of DNA ligase inhibition on the nick sealing of polβ nucleotide insertion products at the downstream steps of base excision repair pathway;Mutagenesis;2024-05-13

4. Exploring phytochemical as potential inhibitors of human DNA polymerase β for targeted ovarian cancer therapy: An In-Silico approach.;2024-03-26

5. Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents;RSC Medicinal Chemistry;2024